Early development obstacles of biosimilars and biobetters

Early development obstacles of biosimilars and biobetters

Gregory K. Bell
Life Sciences

Dr.Gregory K. Bell is quoted in this article published by BioPharm International about the regulatory and legal issues associated with bringing recent biosimilars and biobetters to market. Click below to read the article. 

BioPharm International